11月 2025
- 首頁
- Deciphera
11月 2025Deciphera的市場佔有率分析
at deciphera, we remain steadfast in our mission to improve the lives of people living with cancer - and that passion for making a difference extends to the patient groups and communities in which we live and work.
Deciphera(包含公司地區)
查看更多網站流量與參與度資訊- deciphera.com
Deciphera截至 11月 2025 的總收入為 100M - 200M
Deciphera 熱門網域產生的總收入
Deciphera 熱門網域 3 年內的總收入
Deciphera 熱門網域的總收入
Deciphera的熱門網域總造訪量
了解Deciphera市場觸達率與潛在市場影響力。
過去 3 個月的訪問總量
子公司細目
Deciphera的熱門網域平均造訪時長
分析Deciphera參與度指標。
過去 3 個月平均造訪時長
子公司細目
Deciphera的熱門網域平均頁面瀏覽量
了解Deciphera如何保持使用者的參與度、培養其興趣,並鼓勵他們採取下一步。
過去 3 個月平均頁面瀏覽量
子公司細目
想要取得更深入的流量洞見?
篩選超過 2,030 萬家線上企業。在流量激增、開始或停止使用技術或獲得正面評價時,發現新的潛在客戶。
新聞與訊號來自Deciphera
透過 Similarweb 銷售訊號提醒,每當目標受眾出現新的機會或威脅時,你就會收到每日更新的已識別購買訊號。
新聞Deciphera Pharmaceuticals, Inc. attends event 67th American Society of Hematology (ASH) Annual Meeting.Deciphera announces oral presentation of positive topline Results from Phase 2a study of sapablursen in Polycythemia Vera at the 67th American Society of Hematology (ASH) Annual Meeting.
12月 6, 2025閱讀更多
新聞Flynn retired from Deciphera Pharmaceuticals, Inc. as president, CEO and chief scientific officer on Dec 8th '23.Flynn recently retired from a 20-year tenure at Deciphera where he was founder and served as president, CEO and chief scientific officer.
1月 8, 2024閱讀更多
新聞Deciphera Pharmaceuticals, Inc. recognized as top of the Drug Manufacturers - Specialty & Generic industry.Deciphera Pharmaceuticals Inc (DCPH) is around the top of the Drug Manufacturers - Specialty & Generic industry according to InvestorsObserver.
1月 2, 2024閱讀更多
查看所有Deciphera信號
讓銷售團隊專注於最有希望的機會。透過安排機會的優先順序,並在正確的時間參與,您可將工作最佳化,並完成更多交易。